• Gene Information Directly to Doctors

    Bio-IT World | Last week, GenoSpace, PathGroup and Thomson Reuters announced an expansion of PathGroup’s SmartGenomics product to include Thomson Reuters’ information on genes, variants and therapeutic implications, and GenoSpace’s advanced analytical and information integration capabilities.

    Aug 20, 2013

  • Bina Launches Bina On-Demand, Exome Analysis

    Bio-IT World | Bina Technologies has launched two new capabilities making their big data genomics platform accessible to more users. Whole Exome Analysis and Bina On-Demand expand the user base for the company’s hardware appliance that quickly handles assembly and alignment of raw reads and variant calling in next generation sequencing.

    Aug 19, 2013

  • BIO on the JOBS Act

    US News and World Report | Jim Greenwood, President and CEO of the Biotechnology Industry Organization, reports on the effects of the JOBS Act on the biotech industry.

    Aug 19, 2013

  • Dell Reports 72% Profit Drop

    Computerworld | Dell, in the midst of a privatization push by founder and CEO Michael Dell, reported a 72% profit drop yesterday.

    Aug 16, 2013

  • The Work You Do to Help Save Lives Can Also Save Jobs

    Bio-IT World | Guest Commentary | For many small to midsized businesses, the downturn of the U.S. economy in recent years has led to smaller salaries, decreased revenue, and in many cases, the loss of valuable employees. Unfortunately while small to midsized companies suffer the consequences of a struggling economy, some larger corporations have left their counterparts behind thanks to the research and development (R&D) tax credit.

    Aug 16, 2013

  • Regeneron's Good Business

    Forbes | Regeneron Pharmaceuticals is ranked #4 on Forbes list of most innovative companies for their combination of smart science and smart business.

    Aug 15, 2013

  • Biotech's IPO Breakdown

    Forbes | It's been a banner year for biotech IPOs--27 have gone public since January. Forbes breaks down who, when, and how much.

    Aug 14, 2013

  • Bind Therapeutics Announces IPO

    Boston Globe | Bind Therapeutics filed an IPO registration yesterday, planning to raise $80.5 million. The company said it has already raised $94.7 million.

    Aug 13, 2013

  • Perakslis Joins Precision for Medicine

    Bio-IT World News Brief | Eric Perakslis has joined Precision for Medicine, Inc. as Senior Advisor, Bioinformatics and Information Technology. Precision is a specialized scientific services company formed in 2012 to support next generation medical products. The company is headquartered in Bethesda, Md with offices in Frederick, Md and Cambridge, Mass.

    Aug 13, 2013

  • Nimbus Offers All-Flash Systems with 1x Nanometer Flash

    Bio-IT World | Nimbus Data Systems has announced its fourth-generation all-flash arrays: the Gemini F400 and F600. Thomas Isakovich, CEO of Nimbus Data, tells Bio-IT World that the new offerings will mark a tide change in how widely flash is used, especially in technical computing sectors like the life sciences.

    Aug 12, 2013

  • GenoSpace, PathGroup, Thomson Reuters Launch Oncology Personalized Medicine Service

    Bio-IT World News Brief | GenoSpace, PathGroup and Thomson Reuters have launched an initiative to develop and deliver a best-in-class personalized medicine service for oncology.

    Aug 12, 2013

  • The Cost of Drugs Today

    Forbes | A Forbes analysis finds that a company hoping to get a single drug to market can expect to have spent $350 million before the medicine is available for sale.

    Aug 12, 2013

  • Predicting Preterm Birth

    The Scientist | GNS Healthcare and Inova Translational Medicine Institute are collaborating to predict preterm birth. Using GNS's big data analytics platform and Invoa medical records, the groups hope to identify biomarkers that could predict early births.

    Aug 12, 2013

  • Big Data at the NIH

    CTOvision | Mark Guyer, deputy director of the NIH’s National Human Genome Research Institute (NHGRI), speaks with CTOvision about the big data centers of excellence, and the trends in data sharing.

    Aug 12, 2013

  • Gene By Gene to Acquire Arpeggi

    Bio-IT World | Arpeggi announced yesterday its impending acquisition by Gene By Gene, a Houston-based consumer genomics company that develops products for ancestry and genealogy applications. The new company hopes to make available an innovative suite of more affordable genetics testing and diagnostics services to consumers, researchers and healthcare providers.

    Aug 7, 2013

  • The Henrietta Compromise: NIH Announces HeLa Data Use Agreement

    Bio-IT World | The National Institutes of Health announced this morning that it has reached an “understanding” with the family of Henrietta Lacks to allow controlled access to whole genome sequence data from HeLa cells, the cells derived without consent from the tumor of Henrietta Lacks in 1951.

    Aug 7, 2013

  • Fast Science: Real Time Genomics Moves to Mendelian Diseases

    Bio-IT World | Real Time Genomics chose cows for their first proof of principle, but a lot has changed in the 18 months since I sat down in their Hamilton, New Zealand, offices and toured a dairy farmer’s cooperative down the road. Today RTG’s extremely fast genomics analytics platform is proving itself faster, cheaper and more efficient than the competition for tackling Mendelian genetics.

    Aug 6, 2013

  • 23andMe Launches TV Ads for DTC Genomics

    Bio-IT World News Brief | 23andMe has launched a television advertising campaign. Portraits of Health focuses on educating consumers about how understanding their DNA can help them make more informed and proactive health decisions, while building brand awareness for 23andMe.

    Aug 6, 2013

  • Combination Therapy Targets Breast Cancer that has Spread to Brain

    UCLA Newsroom | Using a mouse-model system, researchers at UCLA Jonsson Comprehensive Cancer Center have combined cellular therapy and gene therapy to develop a possible treatment for breast cancer that has spread to the brain.

    Aug 6, 2013

  • Kickstarting Cancer

    Forbes | What would crowd funding for cancer look like? A Forbes contributor suggests a Kickstarter campaign focusing on individuals with cancers that aren't responding to treatment or aren't well-characterized.

    Aug 5, 2013